We do the research together

Postdoctoral position available! More information on the Research Blog.

PD Dr. med. Jan-Henning Klusmann

Henning is our principal investigator, ERC grantee and a consultant at Hannover Medical School.

Dr. rer. nat. Dirk Heckl

Dirk is our principal investigator and Max Eder Fellow. He specializes in lentiviral CRISPR-Cas9 systems and modeling leukemia in mice.

Dr. Raj Bhayadia

Raj is a postdoctoral fellow working on long non-coding RNAs and patient-derived xenotransplantation models of pediatric AML.

Maurice Labuhn

Maurice (PhD student, HBRS Molecular Medicine) is using a lentiviral CRISPR-Cas9 system to model Down syndrome AML in vivo and in vitro.

Oriol Alejo

Oriol (PhD student, independent) is investigating the interactive genetic network of the stem cell miRNA cluster miR-99a/105~125b.

Sofia Gialesaki

Sofia (PhD student, HBRS Molecular Medicine) is studying the interplay between chromome 21 genes and GATA1s in Down syndrome AML.

Michelle Ng

Michelle (PhD student, HBRS Molecular Medicine) is using a CRISPR interference-based screening platform to investigate the role of long non-coding RNAs in AML.

Dorit Schneider

Dorit (PhD student, HBRS Molecular Medicine) is studying the deregulated network in Ezh2-mutated AML using state-of-the-art CRISPR-Cas9 technology.

Lonneke Verboon

Lonneke (PhD student, independent) is interrogating interactions within the DLK1-DIO3 non-coding RNA locus in hematopoiesis and infant AML.

Sabine Knöß

Sabine (technician) models AML using lentiviral CRISPR-Cas9 systems in vitro.

Meriame Nassiri

Meriame (technician) supports the in vivo mouse models of all projects.

Christina Reimer

Christina (technician) works on non-coding RNAs in AML.